19613 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 393 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
CHMP7Charged multivesicular body protein 7Predicted intracellular proteins
Nucleus
Cytosol
Tissue enhanced
CHN1Chimerin 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
CytosolRenal cancer: 5.07e-4
Group enriched
CHN2Chimerin 2Plasma proteins
Predicted intracellular proteins
NucleusTissue enhanced
CHODLChondrolectinPredicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 1.18e-6
Tissue enhanced
CHORDC1Cysteine and histidine rich domain containing 1Predicted intracellular proteins
CytosolLiver cancer: 4.93e-7
Renal cancer: 1.88e-4
Expressed in all
CHP1Calcineurin like EF-hand protein 1Plasma proteins
Predicted intracellular proteins
VesiclesRenal cancer: 2.79e-6
Liver cancer: 4.07e-6
Endometrial cancer: 9.63e-4
Expressed in all
CHP2Calcineurin like EF-hand protein 2Cancer-related genes
Predicted intracellular proteins
Group enriched
CHPFChondroitin polymerizing factorEnzymes
Predicted intracellular proteins
Predicted secreted proteins
Vesicles
Centrosome
Cytosol
Cervical cancer: 1.57e-4
Head and neck cancer: 1.68e-4
Urothelial cancer: 2.96e-4
Glioma: 9.56e-4
Expressed in all
CHPF2Chondroitin polymerizing factor 2Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Cytosol
Pancreatic cancer: 2.51e-4
Liver cancer: 9.47e-4
Expressed in all
CHPT1Choline phosphotransferase 1Enzymes
Predicted membrane proteins
VesiclesThyroid cancer: 7.41e-4
Expressed in all
CHRAC1Chromatin accessibility complex 1Predicted intracellular proteins
NucleusLiver cancer: 4.88e-5
Endometrial cancer: 2.28e-4
Pancreatic cancer: 5.43e-4
Ovarian cancer: 9.72e-4
Expressed in all
CHRDChordinPlasma proteins
Predicted secreted proteins
Renal cancer: 6.09e-7
Mixed
CHRDL1Chordin like 1Disease related genes
Predicted secreted proteins
Urothelial cancer: 2.23e-4
Renal cancer: 2.36e-4
Tissue enhanced
CHRDL2Chordin like 2Predicted intracellular proteins
Predicted secreted proteins
MitochondriaUrothelial cancer: 6.08e-4
Group enriched
CHRFAM7ACHRNA7 (exons 5-10) and FAM7A (exons A-E) fusionPredicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CHRM1Cholinergic receptor muscarinic 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nucleus
Cytosol
Group enriched
CHRM2Cholinergic receptor muscarinic 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM3Cholinergic receptor muscarinic 3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Plasma membraneTissue enhanced
CHRM4Cholinergic receptor muscarinic 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nucleus
Golgi apparatus
Tissue enhanced
CHRM5Cholinergic receptor muscarinic 5FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CHRNA1Cholinergic receptor nicotinic alpha 1 subunitDisease related genes
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
CHRNA10Cholinergic receptor nicotinic alpha 10 subunitFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
CHRNA2Cholinergic receptor nicotinic alpha 2 subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
CHRNA3Cholinergic receptor nicotinic alpha 3 subunitFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
CHRNA4Cholinergic receptor nicotinic alpha 4 subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNA5Cholinergic receptor nicotinic alpha 5 subunitPredicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Focal adhesion sites
Lung cancer: 3.64e-5
Mixed
CHRNA6Cholinergic receptor nicotinic alpha 6 subunitPredicted intracellular proteins
Predicted membrane proteins
Not detected
CHRNA7Cholinergic receptor nicotinic alpha 7 subunitFDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNA9Cholinergic receptor nicotinic alpha 9 subunitPredicted membrane proteins
Tissue enhanced
CHRNB1Cholinergic receptor nicotinic beta 1 subunitDisease related genes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Expressed in all
CHRNB2Cholinergic receptor nicotinic beta 2 subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CHRNB3Cholinergic receptor nicotinic beta 3 subunitPredicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
CHRNB4Cholinergic receptor nicotinic beta 4 subunitFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
CHRNDCholinergic receptor nicotinic delta subunitDisease related genes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol
Tissue enriched
CHRNECholinergic receptor nicotinic epsilon subunitDisease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CHRNGCholinergic receptor nicotinic gamma subunitDisease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CHST1Carbohydrate sulfotransferase 1Enzymes
Predicted secreted proteins
Renal cancer: 4.64e-7
Liver cancer: 3.95e-4
Tissue enhanced
CHST10Carbohydrate sulfotransferase 10Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolPancreatic cancer: 4.05e-4
Tissue enhanced
CHST11Carbohydrate sulfotransferase 11Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusRenal cancer: 7.59e-11
Urothelial cancer: 8.42e-4
Mixed
CHST12Carbohydrate sulfotransferase 12Enzymes
Predicted membrane proteins
Golgi apparatusPancreatic cancer: 1.32e-5
Expressed in all
CHST13Carbohydrate sulfotransferase 13Enzymes
Predicted secreted proteins
Tissue enhanced
CHST14Carbohydrate sulfotransferase 14Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
VesiclesExpressed in all
CHST15Carbohydrate sulfotransferase 15Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Centrosome
Cytosol
Renal cancer: 2.22e-7
Expressed in all
CHST2Carbohydrate sulfotransferase 2Predicted membrane proteins
Golgi apparatusMixed
CHST3Carbohydrate sulfotransferase 3Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Golgi apparatus
Cytosol
Mixed
CHST4Carbohydrate sulfotransferase 4Predicted secreted proteins
Liver cancer: 9.24e-4
Tissue enriched
CHST5Carbohydrate sulfotransferase 5Predicted membrane proteins
Predicted secreted proteins
Group enriched
CHST6Carbohydrate sulfotransferase 6Disease related genes
Predicted secreted proteins
Tissue enhanced
CHST7Carbohydrate sulfotransferase 7Enzymes
Predicted secreted proteins
Cervical cancer: 7.20e-4
Mixed
CHST8Carbohydrate sulfotransferase 8Disease related genes
Predicted secreted proteins
Tissue enhanced
« prev | Page of 393 | next »